- Home
- Pathology Industry
- Cystic Fibrosis Market and Forecasts, June 2013
Industries
- Pathology (65)
- Drug and Medication (23)
- Genomics (12)
- Biotechnology (11)
- Managed Care (9)
-
- Drug Discovery and Development (8)
- Pharmaceutical (8)
- Blood Supply, Tissue Banking and Transplantation (6)
- Medical Facility (5)
- Diagnostics (4)
- General Medicine and Specialty Medicine (4)
- Biopharmaceutical (3)
- Energy & Environment (3)
- Healthcare (3)
- In Vitro Diagnostic (3)
- Water Distribution and Treatment (2)
- Agriculture (1)
- Agrochemical (1)
- Beverage (1)
- Biological Therapy (1)
Top countries
Publication dates
All regions
data types
- All
- Company Data (426)
- Industry Data
- Country Data (73)
Cystic Fibrosis Market and Forecasts, June 2013
You might be interested in: health insurance, clinical trial, hospital, more »
industry reports
Cystic Fibrosis in The United States : Innovation and Technology Trends (cystic fibrosis, diarrhea)
- Industry report
- January 2012
- 13 pages
... Jpg & - Genetic facts - - Modern diagnosis - http ...
- Industries: Pathology
- Countries: United States
U.S. Autism Industry (autism, cystic fibrosis)
- Industry report
- February 2012
- 14 pages
... While mental retardation, down syndrome and cystic fibrosis remain relatively the same. A january 2009 uc mind institute study refutes this notion. 9.While the cause of autism remains unclear, current ...
- Industries: Pathology
- Countries: United States
Hepatitis C in The United States and Canada : Innovation and Technology Trends (hepatitis c, rheumatoid arthritis, cystic fibrosis)
- Industry report
- May 2011
- 19 pages
... Diseases can lead better lives Vertex scientists and our collaborators are working on new medicines to cure or significantly advance the treatment of hepatitis c, cystic fibrosis, rheumatoid arthritis ...
- Industries: Pathology
- Countries: United States, Canada
The Australian Pharmaceutical Industry : Innovation and Technology Trends
- Industry report
- November 2012
- 21 pages
... Independent confirmation of science & clinical need Non-financial support starting to happen Possibility of future financial support reprinted from Call for outline of expression of interest: cystic ...
Pharmaceutical Market in The United States
- Industry report
- September 2011
- 21 pages
... Every year) usa 3 Million cases (30k newly diagnosed every year) the cdc inhaled aat cystic fibrosis (cf) ~100,000 cases worldwide www.Cff.Org bronchiectasis >100,000 cases in the us (not ...
- Industries: Pathology
- Countries: United States
The New Zealander Pharmaceutical Business
- Industry report
- October 2012
- 28 pages
... The cystic fibrosis foundation (cff) due to dissatisfaction with the current level of care Parents became the major driver for organization to remain focused on its core mission: to improve outcomes ...
- Industries: Pathology
- Countries: New Zealand
Pharmaceutical Business in The United Kingdom, The United States and Sudan
- Industry report
- May 2011
- 5 pages
... Idu) for cystic fibrosis patients. 1.14 I am delighted that alice leahy, consultant paediatric rheumatologist, has been able to secure widespread support across wessex for the creation of a wessex ...
- Industries: Pathology
- Countries: United Kingdom, United States, Sudan
Pharmaceutical Market Overview
- Industry report
- August 2012
- 21 pages
- by Corporation
... Newly discovered therapeutic roles indication status aatd launched bronchiectasis [phase ii ] cystic fibrosis [phase ii ] type-1 diabetes [phase ii ] copd [pre-clinical] transplant rejection [pre ...
- Industries: Pathology
Pharmaceutical Sector in The United States and Israel
- Industry report
- June 2012
- 19 pages
- by Corporation
... Amp; newly discovered therapeutic roles indication status aatd launched bronchiectasis [phase ii ] cystic fibrosis [phase ii ] type-1 diabetes [phase ii ] copd [pre-clinical] transplant rejection [pre ...
- Industries: Pathology
- Countries: United States, Israel
Pharmaceutical in The United States : Innovation and Technology Trends
- Industry report
- July 2011
- 6 pages
- by Corporation
... Expects that future development cands from its programs would be focused on a wide variety of diseases and conditions, including cancer , cystic fibrosis and pain. The company currently relies ...
- Industries: Pharmaceutical
- Countries: United States
Reportlinker.com © Copyright 2013. All rights reserved.
